Paper4571237
Tumor immunity to murine plasma cell tumors. I. Tumor-associated transplantation antigens of NZB and BALB-c plasma cell tumors.
Röllinghoff M and 2 others. J Natl Cancer Inst, 1973. Cited by 81 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Download JSON
Cite this record
ConductScience Library. Tumor immunity to murine plasma cell tumors. I. Tumor-associated transplantation antigens of NZB and BALB-c plasma cell tumors. Papers, record 4571237. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4571237
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Tumor immunity to murine plasma cell tumors. I. Tumor-associated transplantation antigens of NZB and BALB-c plasma cell tumors.
- PubMed
Topics22
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigens, Neoplasm | Major topic |
| Bone Neoplasms | Major topic |
| Histocompatibility Antigens | Major topic |
| Plasmacytoma | Major topic |
| Animals | |
| Antibody-Producing Cells | |
| Cell Line | |
| Cytotoxicity Tests, Immunologic | |
| Female | |
| Fluorescent Antibody Technique | |
| Immunization | |
| Immunization, Passive | |
| Iodine Isotopes | |
| Male | |
| Mice | |
| Mice, Inbred BALB C | |
| Mice, Inbred C57BL | |
| Mice, Inbred NZB | |
| Neoplasm Transplantation | |
| Neoplasms, Experimental | |
| Spleen | |
| Transplantation, Homologous |
Source PubMed
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 81 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 8,422,666 | Characterization of the exogenous interleukin-2 requirements for the generation of enhanced antitumor cytotoxicity by thymocytes from low-dose melphalan-treated MOPC-315 tumor bearers. | Cancer Immunol Immunother | 1993 | https://conductscience.org/library/papers/8422666 | PubMed |
| 8,168,116 | Transforming growth factor-beta-mediated down-regulation of antitumor cytotoxicity of spleen cells from MOPC-315 tumor-bearing mice engaged in tumor eradication following low-dose melphalan therapy. | Cancer Immunol Immunother | 1994 | https://conductscience.org/library/papers/8168116 | PubMed |
| 7,882,386 | Neurotransmitter suppression of the in vitro generation of a cytotoxic T lymphocyte response against the syngeneic MOPC-315 plasmacytoma. | Cancer Immunol Immunother | 1995 | https://conductscience.org/library/papers/7882386 | PubMed |
| 7,002,770 | Presence of a tumour-inhibiting factor (TIF) in sera from normal but not tumour-bearing mice. | Immunology | 1980 | https://conductscience.org/library/papers/7002770 | PubMed |
| 6,553,510 | Increase in the effectiveness of melphalan therapy with progression of MOPC-315 plasmacytoma tumor growth. | Cancer Immunol Immunother | 1983 | https://conductscience.org/library/papers/6553510 | PubMed |
| 6,435,857 | Melphalan-mediated potentiation of antitumor immune responsiveness of immunosuppressed spleen cells from mice bearing a large MOPC-315 tumor. | Cancer Immunol Immunother | 1984 | https://conductscience.org/library/papers/6435857 | PubMed |
| 6,265,346 | Regulation of immune responses against the syngeneic ADJ-PC-5 plasmacytoma in BALB/c mice. I. Analysis of immune parameters involved. | Immunology | 1981 | https://conductscience.org/library/papers/6265346 | PubMed |
| 6,215,340 | Regulation of immune responses aginst the syngeneic ADJ-PC-5 plasmacytoma in BALB-c mice. III. Induction of specific T suppressor cells to the BALB/c plasmacytoma ADJ-PC-5 during early stages of tumorigenesis. | Immunology | 1982 | https://conductscience.org/library/papers/6215340 | PubMed |
| 4,616,826 | Current status of immunotherapy. | Drugs | 1974 | https://conductscience.org/library/papers/4616826 | PubMed |
| 4,541,509 | In vitro induction of tumor-specific immunity. I. Parameters of activation and cytotoxic reactivity of mouse lymphoid cells immunized in vitro against syngeneic and allogeneic plasma cell tumors. | J Exp Med | 1973 | https://conductscience.org/library/papers/4541509 | PubMed |
| 3,989,472 | Inhibition of plasmacytoma development in BALB/c mice by indomethacin. | J Exp Med | 1985 | https://conductscience.org/library/papers/3989472 | PubMed |
| 3,933,817 | Melphalan-induced enhancement of tumor cell immunostimulatory capacity as a mechanism for the appearance of potent antitumor immunity in the spleen of mice bearing a large metastatic MOPC-315 tumor. | Cancer Immunol Immunother | 1985 | https://conductscience.org/library/papers/3933817 | PubMed |
| 3,490,305 | Specificity of the generation and expression of enhanced anti-plasmacytoma immunity by spleen cells from melphalan-treated MOPC-315 tumor bearers. | Cancer Immunol Immunother | 1986 | https://conductscience.org/library/papers/3490305 | PubMed |
| 2,337,902 | Eradication of a large MOPC-315 tumor in athymic nude mice by chemoimmunotherapy with Lyt2+ splenic T cells from melphalan-treated BALB/c mice bearing a large MOPC-315 tumor. | Cancer Immunol Immunother | 1990 | https://conductscience.org/library/papers/2337902 | PubMed |
| 2,289,208 | Presence of an enlarged pool of MOPC-315-specific cytotoxic T lymphocyte precursors in the thymuses of mice that eradicated a large MOPC-315 tumor as a consequence of low-dose melphalan therapy. | Cancer Immunol Immunother | 1990 | https://conductscience.org/library/papers/2289208 | PubMed |
| 1,901,031 | Phorbol ester-induced enhancement in lytic activity of CD8+ splenic T cells from low-dose melphalan-treated MOPC-315-tumor bearers. | Cancer Immunol Immunother | 1991 | https://conductscience.org/library/papers/1901031 | PubMed |
| 1,760,820 | Enhanced expansion of the thymic CD8+ cell subset as a potential mechanism for the generation of enhanced antitumor cytotoxicity by thymocytes from low-dose melphalan-treated MOPC-315 tumor bearers. | Cancer Immunol Immunother | 1991 | https://conductscience.org/library/papers/1760820 | PubMed |
| 629,324 | Loss of oncogenicity and concomitant increased immunogenicity of murine plasmacytoma cell lines. | Am J Pathol | 1978 | https://conductscience.org/library/papers/629324 | PubMed |
| 75,739 | In vitro induction of tumour-specific immunity V. Detection of common antigenic determinatnts of murine fibrosarcomas. | Br J Cancer | 1978 | https://conductscience.org/library/papers/75739 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4571237
GET https://conductscience.org/api/papers/v1/4571237/authors